Burn Injury Clinical Trial
Official title:
Effects of Plasma Therapy in Cutaneous Microcirculation of Different Wounds
NCT number | NCT02417818 |
Other study ID # | 14-266-3 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 2015 |
Est. completion date | February 2023 |
Verified date | February 2023 |
Source | University Hospital Schleswig-Holstein |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In plastic and reconstructive surgery, treatment strategies of second-degree burns, superficial wounds, burn scars, flaps and chronic wounds aim at reducing infection and improving microcirculation. Although previous studies indicate that Plasma Therapy can accelerate wound healing, only a few studies focused on the elucidation of its mechanisms of action. Therefore, the aim of this study is to evaluate the microcirculatory effects of Plasma Therapy on second-degree burns, superficial wounds, burn scars, flaps and chronic wounds in a human in-vivo setting for the first time.
Status | Completed |
Enrollment | 240 |
Est. completion date | February 2023 |
Est. primary completion date | February 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Group A (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. Group B (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. Group C (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. Group D (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups A-C must be evident. No soft tissue injury must be evident. Group E (n=20): Consent-capable male and female patients =18 years of age who have sustained a second-degree burn on =1% and =30% of the surface of the body. Group F (n=20): Consent-capable male and female patients =18 years of age who require a skin excision for the purpose of a skin graft. The minimal size of the skin-graft donor site must not be less than 1% of TBSA. Group G (n=20): Consent-capable male and female patients =18 years of age suffering from a wound that has not yet healed =3 weeks. The minimal size of the wound site must not be less than 1% of TBSA. Group H (n=20): Consent-capable healthy male and female probands =18 years of age serving as sham group. None of the the criteria of groups E-G must be evident. No soft tissue injury must be evident. Group I (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn wound. Group J (n=20): Consent-capable male and female patients =18 years of age suffering from a hypertrophic burn wound. Group K (n=20): Consent-capable male and female patients =18 years of age received a flap. Group L (n=20): Consent-capable male and female patients =18 years of age received a flap. Exclusion Criteria: General exclusion criteria - below 18 years of age - wounds requiring artificial respiration, since consent for the study participation is unobtainable Exclusion criteria groups A, B, D, E, F, H: - peripheral arterial occlusive disease - vasculitis - diabetes mellitus - chronic kidney or liver disease - cardiac dysfunction - arterial hypo- or hypertension Anamnestic exclusion criteria - ongoing immunosuppressive or chemotherapy treatment - drug abuse - systemic skin diseases - systemic and local cortisone therapy |
Country | Name | City | State |
---|---|---|---|
Germany | University of Schleswig-Holstein | Lübeck | Schleswig-Holstein |
Lead Sponsor | Collaborator |
---|---|
University Hospital Schleswig-Holstein |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in microcirculation (composite measure) | capillary blood flow [arbitrary units AU]
capillary blood velocity [AU] tissue oxygen saturation [%] relative postcapillary venous filling pressure [AU] |
Baseline and 1 minute post-dose | |
Secondary | Change in microcirculation (areolar measure) | tissue oxygen saturation [%]
tissue hemoglobin index |
Baseline, while and 1 minute post-dose |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT02241941 -
Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury
|
Phase 4 | |
Completed |
NCT02210208 -
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
|
N/A | |
Completed |
NCT05063409 -
Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting
|
N/A | |
Completed |
NCT03730688 -
Non-invasive Limb Compartment Pressure Measurement
|
N/A | |
Recruiting |
NCT04368117 -
STAT: Standard Therapy Plus Active Therapy
|
N/A | |
Terminated |
NCT01773083 -
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
|
Phase 3 | |
Completed |
NCT02092701 -
Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period
|
N/A | |
Recruiting |
NCT06263296 -
Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare
|
N/A | |
Completed |
NCT02145130 -
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
|
Phase 1 | |
Completed |
NCT01618630 -
Amino Acid Supplementation in Recovery From Severe Burns
|
N/A | |
Recruiting |
NCT05876442 -
Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury
|
N/A | |
Completed |
NCT04417439 -
The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
|
||
Completed |
NCT02417805 -
Cutaneous Microcirculation After Remote Ischemic Preconditioning
|
N/A | |
Completed |
NCT02417779 -
Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy
|
N/A | |
Completed |
NCT01404026 -
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
|
N/A | |
Completed |
NCT03204669 -
Trace Element Repletion Following Severe Burn Injury
|
N/A | |
Recruiting |
NCT04947449 -
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
|
||
Not yet recruiting |
NCT05532488 -
Inulin in Burn-induced Insulin Resistance
|
N/A | |
Recruiting |
NCT02189538 -
Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients
|
N/A | |
Completed |
NCT01795079 -
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury
|
N/A |